Immunological patterns identifying disease course and evolution in multiple sclerosis patients

被引:35
作者
Furlan, R
Rovaris, M
Boneschi, FM
Khademi, M
Bergami, A
Gironi, M
Deleidi, M
Agosta, F
Franciotta, D
Scarpini, E
Uccelli, A
Zaffaroni, M
Kurne, A
Comi, G
Olsson, T
Filippi, M
Martino, G
机构
[1] Ist Sci San Raffaele, Neuroimmunol Unit, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Neuroimaging Res Unit, I-20132 Milan, Italy
[4] Karolinska Hosp, Neuroimmunol Unit, S-17176 Stockholm, Sweden
[5] IRCCS Fdn Ist Neurol C Mondino, Lab Neuroimmunol, I-27100 Pavia, Italy
[6] Univ Milan, IRCCS, Osped Maggiore Policlin, Dept Neurol Sci, I-20122 Milan, Italy
[7] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Neuroimmunol Unit, I-16132 Genoa, Italy
[8] S Antonio Abate Hosp, Multiple Sclerosis Ctr, I-21013 Gallarate, VA, Italy
关键词
multiple sclerosis; chemokines; cytokines; real-time RT-PCR; multivariate analysis;
D O I
10.1016/j.jneuroim.2005.04.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reliable, and easy to measure, immunological markers able to denote disease characteristics in multiple sclerosis (MS) patients are still lacking. We applied a multivariate statistical analysis on results obtained by measuring-by real-time RT-PCR-mRNA levels of 25 immunological relevant molecules in PBMCs from 198 MS patients. The combined measurement of mRNA levels of IL-1 beta, TNF-alpha, TGF-beta, CCL20 and CCR3 was able to distinguish MS patients from healthy individuals. CXCR5, CCL5, and CCR3 combined mRNA levels identify primary progressive MS patients while TNF-alpha, IL-10, CXCL10 and CCR3 differentiate relapsing MS patients. Our results indicate that multi-parametric analysis of mRNA levels of immunological relevant molecules in PBMCs may represent a successful strategy for the identification of putative peripheral markers of disease state and disease activity in MS patients. (C) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:192 / 200
页数:9
相关论文
共 41 条
  • [1] Intrathecal sICAM-1 production in multiple sclerosis -: Correlation with triple dose Gd-DTPA MRI enhancement and IgG index
    Acar, G
    Idiman, F
    Kirkali, G
    Özakbas, S
    Oktay, G
    Çakmakçi, H
    Idiman, E
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (02) : 146 - 150
  • [2] Astrocytes are the major intracerebral source of macrophage inflammatory protein-3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro
    Ambrosini, E
    Columba-Cabezas, S
    Serafini, B
    Muscella, A
    Aloisi, F
    [J]. GLIA, 2003, 41 (03) : 290 - 300
  • [3] Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
    Bar-Or, A
    Nuttall, RK
    Duddy, M
    Alter, A
    Kim, HJ
    Ifergan, I
    Pennington, CJ
    Bourgoin, P
    Edwards, DR
    Yong, VW
    [J]. BRAIN, 2003, 126 : 2738 - 2749
  • [4] Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis
    Eikelenboom, MJ
    Killestein, J
    Izeboud, T
    Kalkers, NF
    van Lier, RAW
    Barkhof, F
    Uitdehaag, BMJ
    Polman, CH
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) : 225 - 232
  • [5] Predictive value of MRI findings in multiple sclerosis
    Filippi, M
    [J]. LANCET NEUROLOGY, 2002, 1 (01) : 9 - 9
  • [6] Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
    Franciotta, D
    Martino, G
    Zardini, E
    Furlan, R
    Bergamaschi, R
    Andreoni, L
    Cosi, V
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2001, 115 (1-2) : 192 - 198
  • [7] Immunological indicators of disease activity and prognosis in multiple sclerosis
    Galboiz, Y
    Miller, A
    [J]. CURRENT OPINION IN NEUROLOGY, 2002, 15 (03) : 233 - 237
  • [8] Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS
    Giunti, D
    Borsellino, G
    Benelli, R
    Marchese, M
    Capello, E
    Valle, MT
    Pedemonte, E
    Noonan, D
    Albini, A
    Bernardi, G
    Mancardi, GL
    Battistini, L
    Uccelli, A
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (05) : 584 - 590
  • [9] New concepts in the immunopathogenesis of multiple sclerosis
    Hemmer, B
    Archelos, JJ
    Hartung, HP
    [J]. NATURE REVIEWS NEUROSCIENCE, 2002, 3 (04) : 291 - 301
  • [10] Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes
    Jalonen, TO
    Pulkkinen, K
    Ukkonen, M
    Saarela, M
    Elovaara, I
    [J]. JOURNAL OF NEUROLOGY, 2002, 249 (05) : 576 - 583